Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients

scientific article published on May 1986

Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0142(19860501)57:9<1824::AID-CNCR2820570920>3.0.CO;2-Q
P698PubMed publication ID2420439

P2093author name stringHeitz PU
Klöppel G
Stamm B
Willemer S
Häcki WH
P2860cites workThe use of avidin-biotin interaction in immunoenzymatic techniquesQ39563816
Hypergastrinemia in familial multiple endocrine adenomatosis.Q51676382
Five families with multiple endocrine adenomatosis.Q54572292
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectmultiple endocrine neoplasiaQ1553018
P304page(s)1824-1832
P577publication date1986-05-01
P1433published inCancerQ326041
P1476titlePancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients
P478volume57

Reverse relations

cites work (P2860)
Q80093948A novel Von Hippel-Lindau case with germline mutation at codon 167 (CGG to TGG) having endocrine microadenomatosis of the pancreas
Q35929598Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.
Q37056120Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors
Q38545523Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1.
Q36814297Chronic pancreatitis, pseudotumors and other tumor-like lesions
Q28269657Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS)
Q90075107Colocalization of pancreatic polypeptide and insulin in secretory granules of a pancreatic endocrine neoplasm
Q37023946Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors
Q36539618Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism
Q36994212Gastrinoma--morphological aspects
Q41439923Gastrointestinal endocrine tumours. Pathology
Q68308356Genetic and Clinical Characteristics OF Multiple Endocrine Neoplasia Type 1
Q71827858Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome
Q90075116Gut endocrine and neural peptides
Q36904561Hereditary neuroendocrine tumors of the gastroenteropancreatic system
Q61852968Histopathology, hormone products, and clinicopathological profile of endocrine tumors of the upper small intestine: A study of 44 cases
Q34585323Hyperinsulinemic hypoglycemia due to adult nesidioblastosis in insulin-dependent diabetes
Q24647838Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies
Q72684235Islet cell tumors of the pancreas
Q72254133Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome
Q28088746MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics
Q77292874Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1
Q40624165Molecular mechanisms of neoplasia in multiple endocrine neoplasia type 1-related and sporadic tumors of the pancreatic islet cells.
Q35697715Multidetector CT of multicentric solid pseudopapillary tumor of the pancreas: a case report and review of the literature
Q36063577Multiple Endocrine Neoplasia: Genetics and Clinical Management
Q51493178Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.
Q40471503Multiple endocrine neoplasia type 1 (MEN 1) revisited
Q36739108Multiple endocrine neoplasia type 1- presenting multiple lipomas and hypoglycemia onset
Q34924827Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance
Q34626242Nonductal neoplasms of the pancreas
Q72056447Operative tumour yield obviates preoperative pancreatic tumour localization in multiple endocrine neoplasia type 1
Q79775342Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias
Q69920257Pancreatic endocrine tumors
Q91641409Pancreatic neuroendocrine microadenomatosis presenting as a functional VIPoma
Q36614285Pancreatic polypeptide cell hyperplasia of the pancreas
Q34515753Pancreatic polypeptide-related tumors
Q67522369Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment
Q40712327Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
Q69811777Pituitary prolactinoma, pancreatic glucagonomas, and aldosterone-producing adrenal cortical adenoma: a suggested variant of multiple endocrine neoplasia type I
Q51356001Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1.
Q81290489Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry
Q35922060Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome
Q33258694Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features
Q35934415Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors
Q72179249Surgical management of insulinoma associated with multiple endocrine neoplasia type I
Q26998951Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1
Q47424929Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy
Q36506076Surgical treatment of endocrine pancreatic lesions in MEN-1.
Q93028918The Adult Pancreas in Trauma and Disease
Q46042442The Zollinger-Ellison syndrome. A collective surgical experience
Q57795403The endocrine pancreas and its tumors
Q40723727The pathology of the gastrointestinal endocrine system.
Q52331324The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient
Q42458822The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1.
Q36484987Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome
Q97887355Unusual Combination of MEN-1 and the Contiguous Gene Deletion Syndrome of CAH and Ehlers-Danlos Syndrome (CAH-X)
Q79088475[Tumors of the endocrine pancreas]
Q81112466[Tumors of the endocrine pancreas]

Search more.